Online presence for physicians: Appropriate use of social media
Our interactions and presence on social media have continued to increase, especially during the pandemic when the need and desire to stay connected with one another has been heightened. Many professionals, including physicians, use social media in their practice as an effective tool to communicate and interact with colleagues and patients, market their practice and...
Continue reading the post titled Online presence for physicians: Appropriate use of social mediaNeurontin
In January 2005, Siskinds filed a class proceedings against Pfizer Canada Inc. and Pfizer Inc. with respect to Neurontin. Neurontin (generic name is “gabapentin”) is a prescription anticonvulsant medication approved for use as a therapeutic antiepileptic agent, specifically as an adjunctive therapy for seizures. The vast majority of Neurontin sales are prescribed for “off label”...
Continue reading the post titled NeurontinData Breaches: Do class actions pose a viable remedy?
In 2014, data breach occurrences have increased by approximately 30%. As web-based services become more prominent, protection against and remedies for breaches of privacy will become necessary. Does class action litigation have a place in this shifting landscape? Introduction During the first half of September 2014, the following data breaches, among others, occurred or were...
Continue reading the post titled Data Breaches: Do class actions pose a viable remedy?New brownfields standards coming soon
Ministry of the Environment staff are seeking approval for proposed changes to the brownfields regulation, 153/04. Last year, the MOE proposed far-reaching changes, including: much more stringent generic cleanup standards, to be phased in 12 months later, a more flexible Tier 2 for risk assessment,
Continue reading the post titled New brownfields standards coming soonReceive Blog Posts
By subscribing to our blog, you will receive an email when a new post is added. You can unsubscribe at any time by sending an email to us at [email protected] with the word “unsubscribe” in the subject line.